Dr Alasdair Conn, Chief of Emergency Services at Massachusetts General Hospital stated that two years ago they asked the Israelis to set up a disaster team that could respond to a mass-casualty event. This prepared them for dealing with the … Continue reading →

Israeli start-up Oxitone has developed a blood-oxygen monitor that can be worn on the wrist by those “at risk” to warn of any sudden deterioration in their condition. Oxitone has been selected for GE Healthcare’s Start-Up Health Academy Entrepreneurship Program … Continue reading →

Israel’s BiolineRX has announced positive results for the Phase IIa clinical trial of BL-7040, an oral treatment for inflammatory bowel disease (IBD). Ulcerative colitis and Crohn’s disease affect as many as 1.4 million individuals in the US alone. http://www.globes.co.il/serveen/globes/docview.asp?did=1000836889&fid=1725

Researchers at Tel Aviv University gave electric stimulation to the brains of rats and found that high-frequency “bursts” produced the same destructive plaques found in the brains of Alzheimer’s patients. http://www.jpost.com/Health/Article.aspx?id=309740

18 Israeli companies develop or market cell-based treatment products – an unprecedented large proportion in relation to the country’s population. All of them are attending the Israstem Conference in Ramat Gan starting Apr 22, to discuss stem cells, cell therapy, … Continue reading →

Sheba Medical Center researchers and Israeli start-up Lev-El Diagnostics of Heart Disease have developed an algorithm that could save lives by quickly identifying patients with heart disease. Patients used to have to wear heart monitors for 24 – 48 hours. … Continue reading →